Shockwave Therapy News
-
Shockwave Medical Initiates All-Female Coronary IVL Study
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions Study Seeks to Confirm Benefits of Shockwave’s Coronary IVL in Females Who Historically Have Suffered Less Favorable Clinical Outcomes than Male Patients with Traditional Therapies Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...
-
Third Publication – Transvaginal, low intensity shockwave, for premenopause FSD treatment
The third presentation on the latest treatment approach for Female Sexual Dysfunction (FSD), by Transvaginal Shockwave Therapy (TVST), is to be presented this week at the upcoming European Society of Sexual Medicine. Session PS-01 will be presented by Laszlo Kornya, MD at the upcoming 23rd ESSM Annual Meeting, on Friday, February 18, 2022, at 10:21 AM, in Virtual Room 2 (VR-2). Exhibition this ...
By DirexGroup
-
Promaxo Announces Sale of In-Office MRI to Kasraeian Urology
Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Kasraeian Urology, a Division of Florida Physician Specialists (“Kasraeian Urology”). FDA cleared for in-office use, the Company’s single-sided MRI system with AI based imaging empowers practices and ...
-
SANUWAVE Health Presents dermaPACE System Treatment Study Results Showing Enhanced Localized Wound Tissue Oxygenation
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field today presented results from a clinical case series that demonstrated improved wound healing when treated with its FDA-cleared, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you